Sigyn Therapeutics Appoints Donald J. Hillebrand, M.D. to its Scientific Advisory Board
26 avr. 2022 08h00 HE
|
Sigyn Therapeutics, Inc.
SAN DIEGO, CA, April 26, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTC Markets:“SIGY”), a medical technology company focused on the treatment of pathogen-associated...